Clinical Trial Update: An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates [Phase 1]

View source ↗

Summary

Completed Phase 1 open-label study investigating the effect of amlitelimab on the pharmacokinetics of selected cytochrome P450 substrates to assess potential dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Amlitelimab (amlitelimab)

Snippet

Sponsor: Sanofi | Conditions: Dermatitis Atopic | Phase 1 | Status: COMPLETED